We believe that compliance confidence should belong to the many, not just a few. The Code Clarity Podcast is the first and only podcast relating to ABPI Code compliance - for pharma and associated agencies.
Can a “views are my own” disclaimer really save you from the PMCPA's watchful eye? Spoiler: no. Moderna learns this the hard way. (Case Auth/ 3835/10/23) (1/3)
Rina & Jean dive into the drama of a recent confession by Pierre Fabre & the results of our audience poll... asking the big question: should voluntary admissions come with a checklist… or at least a decent apology template?
The ABPI has recently published guidance on congresses. What does the Code already say on this topic? What does the Guidance include? And what does it all mean. Code Clarity is hosting a webinar on this topic on 6th May 2025, 12.30-1.30pm. Contact us at hello@codeclarity.co.uk for more details.
Jean and Rina discuss a recent case about something said by a Celltrion sales rep - top tips relate to why it's important to prove what you say in calls is correct!
Our poll suggests 85% of you want the QR code to link to SPC OR for HCPs to refer to the SPC. So is this the beginning of the end for Prescribing Information?
A recent case about a gay dating app confirms WHEN the UK Code applies and WHY appeals are worth it.
Yay, a Complaints Masterclass to increase your confidence when it comes to self-regulation - from experts in complaints management! Register your interest: hello@codeclarity.co.uk (15th May 2025, 1.30-4.30pm, Woburn House, London, WC1H 9HQ)
An update on case rulings that may affect the way UK Pharma can do Medical Education - what's changed and what can we learn? Cases discussed are AUTH/3832/10/23 and AUTH/3825/9/23
Recent news about Astellas merging C-suite roles (medical and commercial) - what's the fuss about? And top tips if you're considering the same.
Rina & Jean discuss a recent appeal by Janssen relating to UK speakers presenting at international meetings - why was the appeal so good?!
Becs Shuttleworth joins Rina & Jean to explain the importance of bringing compliance into the light.
Yay the first abridged procedure case vs CSL Seqirus has been published! A dull case but Rina covers the 2 interesting points to take away
Oh dear - an employee of a competitor company lobs a rubbish complaint to the PMCPA and wow - they have to accept, as it's non-contactable. MADNESS.
How to influence Code changes (yes it can be done!) & tips about the practical implementation of QR Codes with Jenni Harrison and Richard Blackwell. If you need confidence, here's a link to our compliance checklist on QR codes.
Pharma supporting HCPs to attend meetings - Code vs PMCPA guidance vs our thoughts on the simple ways to achieve compliance.
Why were there so many breaches about CLAIMS in 2024? W2 discuss our 3 top tips to help you tackle this risk.
A painful PMCPA press release but our 3 minute takeaway to simplify matters.
It's no surprise who the "winner" is here, but Rina & Jean discuss the many factors involved in what makes a BIG case.
...errr...don't mention product. A recent breach for AbbVie and our advice on common sense.
Rina chats to Dr Tim Ringrose (CEO, Cognitant) about empowering patients with long-term conditions with digital tools, and how his workshop at this year's Code Clarity conference will focus on this and positive case studies.
Rina & Jean dissect the key highlights from the latest PMCPA report - what does it really tell us about their finances...
Lawyers and the ABPI Code - responding to complaints, writing up case rulings, ruling on cases - our honest thoughts.
Everyone's worried about possible complaints if they use AI in MLR/copy approval. Rina & Jean discuss the likely scenarios and spolier alert - it's not that bad.
OF COURSE this week's podcast is about the newly published ABPI Code 2024.In a surprise twist that shocked even them, find out what Rina & Jean love (strongly like) about the Code updates and why. For more info, do join our 10 Oct webinar!
Why is it so hard for the public to make a complaint to the PMCPA? We discuss a recent case* and constructive ways this could be made much easier, clearer and fairer. *Case AUTH/3717/12/22 See S2 E12 for top tips to make a complaint if you're in pharma.
We chat about the most common compliance concern expressed to us about AI: "AI will never be error-free!". Join us at this year's conference for a workshop on the "Practical Appliations of GenAI in Pharma".
After a great summer, Jean and Rina recommend some books* and discuss how a quote resonated strongly with Code Clarity's vision around digitalising compliance confidence for the many. * Stolen Focus / The Almanack of Naval Ravikant
Rina & Jean are back from their Tenerife pool parties and their last S2 podcast discusses their predictions for the new ABPI Code 2024 and changes at the PMCPA… Tune in again in Sept to see if any turn out to be right! But in the meantime thank you for listening and enjoy your summers ☀️
A new pharma employee asked us about using LinkedIn - hear our advice or access our checklist.
Rina discusses a recent complaint vs GSK - it did not breach the Code but WHY? Jean asks all the questions a good signatory should be considering based on our checklist. See Code Clarity's LinkedIn page to see a similar TV ad.
Sophie Hodge from Medaptive shares her experience and recommendations on becoming a Signatory (spoiler alert - there's not a shortcut!)
Why are there still so many breaches about claims?! Rina & Jean discuss why these may appear and why pushing the boundaries is important.
LinkedIn does not allow promotion via InMail - a recent case (https://bit.ly/44y9YyB) vs Tetris tells us about targeting and the importance of social media platform policies.
Trends from Q1 published PMCPA rulings show a staggering 96% allege poor standards - what does this mean and what can we do about this?
Sarah Hollywood from HollywoodMedico chats to Jean about ' bad blocker' signatories and provides tips on how 'good' signatories can give teams the competitive edge.
Rubbish complaints cause confusing PMCPA rulings which lead to pharma's lack of clarity. Here are 5 top tips to lodge the "perfect" complaint to the PMCPA.
Patient Organisations often receive support from pharma companies BUT Case AUTH/3676/7/22 vs Roche helps us understand respective liabilities. Interested to learn the why, what and how? Come along to our Case Awareness Surgery on 2 May 2024 or ask us for the recording.
Three top tips from a good discussion about 2 cases and senior leader activities on social media - don't stop, challenge the PMCPA and appeals are worth it!! Case AUTH/3741/2/23 Case AUTH/3707/11/22
We discuss the results of a recent LinkedIn poll and the ruling for Pfizer which suggest employees should review their past social media engagements - but that does not mean STOP engaging!
How to reduce confusion, encourage good record-keeping and stay complaint when briefing reps about call rates.
Sensational language, Mail article...yet no breach for GSK! Rina & Jean discuss why (Case AUTH/3691/9/22). A must listen for your comms team!
A LinkedIn poll recently confirmed that a compliance award could be based on bold ideas... Rina & Jean discuss why, what and how compliance can be celebrated alongside creativity. One for you and your agencies!
A recent case ruling (Case AUTH/3656/6/22) might leave you worried but we have three tips on how these interviews can be done well AND compliantly.
Our recent LinkedIn poll suggests 90% believe pharma's agencies should be Code-trained. Listen to our 3 top tips about the why, what and how representing best practice for ALL agencies.
Rina & Jean chat about how the PMCPA ruled (Case AUTH/3662/6/22) for a case about dynamic content generated from sharing buttons. Can they move? Should they be certified? Or simply checked?
Aargh with no definition of a promotional claim in the ABPI Code AND a terrible definition for a promotional aid, is it any wonder we are confused? Rina & Jean suggest a clear solution (after a little bit of moaning). See our comments and please send yours by 29 Feb 24, link here).
Rina & Jean discuss the proposed change in the 2024 Code for signatories requiring validation. Our top tips? Start PLANNING now, list out TASKS and COMMENT on the changes (see our comments and please send yours by 29 Feb 24, link here).
Rina & Jean reflect on all the great discussion from the Code Clarity Conference and what comments could be made on the upcoming PMCPA consultation.
Deaghlan O'Hagan joins Rina to discuss the why, who and what of anon complaints, covering 3 pain points and potential solutions.
Complaints about "garbage" need to be specific! Jean covers Case AUTH/3696/10/22 and why SOBI were ruled not in breach.
Sick of long e-sales aids that contain too much info about clinical trials? Is this less or more of a compliance risk? Listen as we suggest practical solutions.
© 2020-2025 Ivy Podcast Discovery LLC
